Interferon-α (INF-α)-Yaohai Biopharmaceutical Co., Ltd.

Modality

Interferon-α (INF-α)

Interferons (INFs) are cytokines secreted during the early stages of viral infection that have antiviral and antiproliferative effects. Three types of INFs are present in the human body: INF-α, INF-β, and INF-γ. The INF-α subtypes is the most widely used INF for therapeutic purposes.

Recombinant INF-α and PEG-conjugated INF-α are currently approved for curing patients suffered from viral infections and cancers, such as hepatitis B, hepatitis C, and malignant melanoma.

Recombinant INF-α is typically produced in Escherichia coli (E. coli) and is currently used in clinical practice because it does not require post-translational modification to exhibit biological activity.

Application of Interferon-α (INF-α)

Interferon alfa-2a (INF-α-2a)

Interferon alpha-2a, the active substance of Roferon-A, is a highly purified protein with a molecular weight of approximately 19 kDa and contains 165 amino acids. Developed by Roche and manufactured using recombinant DNA technology, roferon-A applies a genetically engineered Escherichia coli containing DNA that codes for the human protein.

Peginterferon alfa-2a

Pegasys (peginterferon alfa-2a) is a covalent linker consisting of recombinant interferon alfa-2a (approximately 20 kDa) and branched bis-monomethoxy polyethylene glycol (PEG) chains (approximately 40 kDa). Through a stable amide bond to lysine, the PEG moiety binds to the interferon alfa moiety at a single site. Interferon-alpha-2a is manufactured by recombinant DNA technology in which the cloned human leukocyte interferon gene is inserted into and expressed in E. coli. The Pegasys formulation was developed by Roche/Genentech and acquired by zr pharma worldwide (except China and Japan).

Interferon alfa-2b

Produced by recombinant DNA technology, Intron-A (interferon-alpha-2b) is a purified, sterile recombinant alpha interferon product, which is produced by bacterial fermentation of E. coli strain carrying a genetically engineered plasmid that contains the interferon alfa-2b gene extracted from human leukocytes. And intron A was developed by Schering-Plough and Merck Sharp & Dohme.

Peginterferon alfa-2b

Pegintron (peginterferon α-2b) is a covalent bond consisting of recombinant interferon α-2b and monomethoxy polyethylene glycol (PEG). With a molecular weight of 19 kDa, Interferon α-2b is a water-soluble protein and developed by recombinant DNA techniques. Developed by Schering-Plough and Merck Sharp & Dohme, it is produced by bacterial fermentation of an E. coli strain carrying a recombinant plasmid containing the human leukocyte interferon gene.

Interferon for Animal Use

Feline Interferon

Yaohai Bio-Pharma Offers One-Stop CDMO Solution for INF-α

Microbial Strain Engineering and Screening
Microbial Cell Banking (PCB/MCB/WCB)
Upstream Process Development
Downstream Process Development
Formulation Development
GMP Manufacturing
Fill and Finish
Analytical and Testing
Regulatory Affairs

INF-α Pipelines

Generic name	Brand Name/ Alternative name	Expression System	Indications	Manufacturer	Latest stage
Recombinant human interferon α-2b-INTRON A	YM-14090, Viraferon, IntronA, Intron A,甘乐能	Escherichia coli (E. coli)	Tumor, Infectious diseases, Digestive system diseases, blood system diseases	MSD, Merck, schering plough	Approval
Pegylated Interferon α-2b	PegIntron,佩乐能, Redipen, Peg-Intron, Virtron, C-Pegferon, Cylatron	E. coli	Tumor, Infectious diseases, Digestive system diseases, blood system diseases	MSD, Merck, schering plough	Approval
Recombinant human interferon α-2a	ROFERON-A	E. coli	Tumor, Infectious diseases, blood system diseases, Digestive system diseases	Roche	Approval
Polyethylene glycol recombinant interferon α-2a	派罗欣, Pegasys,ペガシス	E. coli	Infectious diseases, Digestive system diseases, Immune system diseases, Tumor, blood system diseases, Urinary system diseases	Nektar Therapeutics, Roche, Aradigm, InterMune, Chugai Pharmaceutical Co., Ltd.	Approval
interferonα-1	Interferon alfacon-1, YM 643, IFN-Con1, Inferax, Advaferon, Infergen	E. coli	Tumor, Infectious diseases	Amgen, Astellas Pharma Inc, Takeda, Kadmon Pharmaceuticals, Chiesi Pharmaceutical (Shangai) Co., Ltd	Approval
Proline interferon α-2b	Ropeginterferon alfa-2b-njft, P-1101, AOP-2014, Besremi,ベスレミ	E. coli	Infectious diseases, Tumor, blood system diseases, Digestive system diseases	PharmaEssentia, AOP Orphan	Approval
Recombinant human interferon α2b (Pseudomonas)	里亚美,利分能	Pseudomonas	Tumor, Infectious diseases	HAPHARM GROUP CO.,LTD.	Approval
Recombinant interferon α-2a	Interferon α-2a-Inmutag, Inferon, Inmutag, Inter 2A	Pending update	Tumor, Infectious diseases	Biosidus	Approval
Recombinant interferon α-2b	peginterferon alfa-2b-Bioferon, Citopheron, Ganapar, Zavinex, Inter 2B	Pending update	Tumor, Infectious diseases	Biosidus	Approval
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	Biocad	Approval
Interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	BioGeneric Pharma SAE	Approval
interferon α-2a	INTEFEN-IFN	Pending update	Tumor, Infectious diseases	Biolotus Biotech Ltda	Approval
interferon α-2a	BLAUFERON-A	Pending update	Tumor, Infectious diseases	Blau Farmacêutica SA	Approval
interferon-α2	Pending update	Pending update	Tumor, Infectious diseases	CJ CheilJedang Corp.	Approval
interferon α-2a biosimilars	r-hu-IFNa2	Pending update	Tumor, Infectious diseases	Elea Spa	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Fundação Oswaldo Cruz	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Getz Pharma Research	Approval
Interferon α-2a	迪恩安	Pending update	Tumor, Infectious diseases	Liaoning Satellite	Approval
Pegylated interferon α2a	Optipeg-A	Pending update	Tumor, Infectious diseases	Incepta Pharmaceuticals Ltd.	Approval
interferonα-2b	Pending update	Pending update	Tumor, Infectious diseases	Intas Biopharmaceuticals	Approval
Pegylated Interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Intas Biopharmaceuticals	Approval
interferonα-2b	Heberon Alfa R, Inrec	Pending update	Tumor, Infectious diseases	International Centre for Genetic Engineering and Biotechnology	Approval
interferonα-2b	Pending update	Pending update	Tumor, Infectious diseases	Keepharma Ltd.	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Laboratorio Varifarma SA	Approval
interferon α-2b	Lanstion	Pending update	Tumor, Infectious diseases	Landsteiner Scientific SA de CV	Approval
Pegylated Interferon α-2b biosimilars	Pegstat	Pending update	Tumor, Infectious diseases	Nanogen Pharmaceutical	Approval
interferon α	OPC-18, IFN-alpha, Alfaferone, Oif	Pending update	Tumor, Infectious diseases	Otsuka Holdings Co., Ltd.	Approval
Recombinant human interferon α	Interferon Alfa	Pending update	Tumor, Infectious diseases	Reliance Life Sciences	Approval
interferon α-2b	ReliFeron	Pending update	Tumor, Infectious diseases	Reliance Life Sciences	Approval
interferon α-2a	Reiferon	Pending update	Tumor, Infectious diseases	Rhein-Minapharm	Approval
interferon α-2b	Kalferon	Pending update	Tumor, Infectious diseases	PT Kalbe Farma Tbk	Approval
interferon α-N3	interferon alfa-N3	NA, extract from leucocytes	Tumor, Infectious diseases	Stem Cell Innovations	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Teva Pharmaceutical Industries Ltd	Approval
Pegylated interferon α2a	Pegaferon	Pending update	Tumor, Infectious diseases	Panpharmaceuticals	Approval
Pegylated Interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Panpharmaceuticals	Approval
interferon α-2b	Altevir	Pending update	Tumor, Infectious diseases	Pharmapark LLC	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	PharmBiotek Research and Production LLC	Approval
interferon α-2b	Alfarona, Alpharona, Alfaron	Pending update	Tumor, Infectious diseases	Pharmaclon	Approval
interferon α-2a	Pending update	Pending update	Tumor, Infectious diseases	Pooyesh Darou Biopharmaceuticals	Approval
interferon α-2b	PDferon-B	Pending update	Tumor, Infectious diseases	Pooyesh Darou Biopharmaceuticals	Approval
interferon α-2b	Urifron	Pending update	Tumor, Infectious diseases	Probiomed SA de CV	Approval
interferon α	Leu-IFN, Multiferon	Pending update	Tumor, Infectious diseases	Viragen, Inc.	Approval
interferon α-2b	VIPEG	Pending update	Tumor, Infectious diseases	Virchow Group	Approval
interferon α-2b	Reaferon-EU-Lipint, Reaferon-EC-Lipint, Reaferon-ES-Lipint	Pending update	Tumor, Infectious diseases	Vektor Medika	Approval
interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Zydus Lifesciences Ltd.	Approval
Pegylated Interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Zydus Lifesciences Ltd.	Approval
interferon α-2b	Intermax Alpha	Pending update	Tumor, Infectious diseases	LG Chem	Approval
interferon α-2b	rHuIFNa-2b,安达芬	Pending update	Tumor, Infectious diseases	Anhui Anke Biotechnology (Group) Co., Ltd	Approval
Recombinant human interferon α-2b	interferon alpha 2b,凯因益生	Pending update	Tumor, Infectious diseases	Beijing Kawin Technology Share-Holding Co., Ltd.	Approval
CePEG-IFN	Cepeginterferon alfa-2b, Algeron, Pegylated human interferon A-2B, CePEG-IFN	Pending update	Tumor, Infectious diseases	Biocad	Approval
interferon α	Interferon alpha vaginal, Interferon alpha vaginal, Opin	Pending update	Tumor, Infectious diseases	Vitapharm Technology	Approval
Recombinant human interferon α2b	Pending update	Pending update	Tumor, Infectious diseases	Yuance	Approval
Recombinant human interferon α2a gel	Recombinant interferon alpha-2a,忆林, Yilin	Pending update	Tumor, Infectious diseases	Changchun ChangSheng Gene Pharmaceutical Co., Ltd	Approval
Recombinant human interferon α2b	长生扶康	Pending update	Tumor, Infectious diseases	Changchun institute of biological products	Approval
interferonα-2a	Pending update	Pending update	Tumor, Infectious diseases	Changchun institute of biological products	Approval
Recombinant human interferon α	Interferon Alfa	Pending update	Tumor, Infectious diseases	Sumitomo Pharma	Approval
Recombinant human interferon α2b	尤尼隆	Pending update	Tumor, Infectious diseases	Hainan Unipul Pharmaceutical Co., Ltd	Approval
interferonα-2a	贝尔芬	Pending update	Tumor, Infectious diseases	Hainan Xinmingda Bio-Pharma	Approval
interferonα-2b	Pending update	Pending update	Tumor, Infectious diseases	Furuibang Group	Approval
Recombinant human interferon α2b	尤靖安	Pending update	Tumor, Infectious diseases	Lee's Pharmaceutical	Approval
Recombinant human interferon α-2a	Interferon alfa 2a	Pending update	Tumor, Infectious diseases	3SBIO	Approval
Y type Polyethylene glycol recombinant interferon α-2b	派格宾	Pending update	Tumor, Infectious diseases	Amoytop	Approval
Recombinant human interferon α2b	万复因	Pending update	Tumor, Infectious diseases	Tenry	Approval
Recombinant human interferon α2a	万复洛	Pending update	Tumor, Infectious diseases	Tenry	Approval
Recombinant human interferon α2b	辛复宁,辛化诺	Pending update	Tumor, Infectious diseases	Shanghai Huaxin Biotechnology Co., Ltd	Approval
Recombinant human interferon α-2b	interferon alpha 2b	Pending update	Tumor, Infectious diseases	Shanghai Wanxing	Approval
Recombinant human interferon α-2a	Interferon alfa 2a	Pending update	Tumor, Infectious diseases	Shanghai Wanxing, Tenry	Approval
Recombinant human interferon α-2b	Recombinant human interferon alpha-2b	Pending update	Tumor, Infectious diseases	Interlong	Approval
Recombinant human interferon α-2b	安福隆,捷抚	Pending update	Tumor, Infectious diseases	SINOBIOWAY Medicine	Approval
interferon α-2b	rHuIFNa-2b	Pending update	Tumor, Infectious diseases	Changchun Heberbiological Technology Co., Ltd	Approval
interferon α-2a	因特芬	Pending update	Tumor, Infectious diseases	3SBIO	Approval
Recombinant human interferon α2b	莱福隆	Pending update	Tumor, Infectious diseases	Beisheng Pharma Hansheng	Approval
Recombinant human interferon α2a	奥平	Pending update	Tumor, Infectious diseases	Wuhan weiao	Approval
Y type Polyethylene glycol recombinant interferon α-2a	Y shaped pegylation interferon α-2a	Pending update	Tumor, Infectious diseases	Amoytop	Phase II/III
Polyethylene glycol recombinant interferon α	Peginterferon alpha	Pending update	Tumor, Infectious diseases	European Organisation for Research and Treatment of Cancer	Phase III
Interferon alpha-2b/interferon gamma	Interferon-gamma/interferon-alpha-2b, CIGB-128, CIGB-128-A	Pending update	Tumor, Infectious diseases	Heber Biotec SA	Phase II
Recombinant human interferon α-2b inhalant -AP003	interferon alpha 2b inhalation-AP003, AntiCovir, AP 003	Pending update	Tumor, Infectious diseases	Altum Pharmaceuticals, BetterLife Pharma	Phase II
Recombinant human interferon α	Interferon Alfa	Pending update	Tumor, Infectious diseases	Amarillo Biosciences	Phase II
Pegylated interferon alpha-2a	PegIFN-alpha2a	Pending update	Tumor, Infectious diseases	Janssen Research & Development LLC	Phase II
IFNα-Kinoid	Human IFN-α2b coupled to a T-helper carrier protein, CKD971, SS-002, SS002, SS 002	Pending update	Tumor, Infectious diseases	Centurion Pharma, Chong Kun Dang, Neovacs, Biosense Global	Phase II
interferonα1b	Peginterferon α1b	Pending update	Tumor, Infectious diseases	Shanghai Institute of Biological Products Co., Ltd	Phase II
interferonα-N1	Interferon alpha-N1	Pending update	Tumor, Infectious diseases	GSK	Phase II
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	Anhui Anke Biotechnology (Group) Co., Ltd	Phase II
interferonα-2b	Hanferon, HL-031	Pending update	Tumor, Infectious diseases	Nautilus Biotech	Phase II
Recombinant human interferon α-2b喷雾剂	Pending update	Pending update	Tumor, Infectious diseases	Anhui Anke Biotechnology (Group) Co., Ltd	Phase II
Recombinant human interferon α-2b	interferon alpha 2b	Pending update	Tumor, Infectious diseases	Hanall	Phase I/II
MSC-IFN α	Pending update	Pending update	Tumor, Infectious diseases	Wuxi Huatai Innovative Pharmaceutical	Phase I/II
SAR441000	an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15	Pending update	Tumor, Infectious diseases	Sanofi, BioNTech	Phase I
Recombinant human serum albumin and interferon α-2b fusion protein	Recombinant human serum albumin and interferon α-2b-kangbao group	Pending update	Tumor, Infectious diseases	Shanxi Kangbao	Phase I
Recombinant human interferon α-2b	interferon alpha 2b	Pending update	Tumor, Infectious diseases	Kexing Biopharma	Phase I
Recombinant human serum albumin interferon α2a fusion protein	Pending update	Pending update	Tumor, Infectious diseases	Qilu Pharmaceutical	Phase I
Recombinant human serum albumin interferon α2a fusion protein	rHSA-IFN alpha-2a, SFR-9213	Pending update	Tumor, Infectious diseases	Fortunerock (China)	Phase I
Recombinant human serum albumin and interferon α-2b fusion protein	Recombinant human serum albumin and interferon α-2b-kangbao group	Pending update	Tumor, Infectious diseases	Anhui Anke Biotechnology (Group) Co., Ltd	Pre-clinical
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	SL Pharm	Pre-clinical
AL-683	Hyperglycosylated IFN Alfacon-1	Pending update	Tumor, Infectious diseases	Alios BioPharma	Pre-clinical
AL-624	Hyperglycosylated IFN Alfacon-1	Pending update	Tumor, Infectious diseases	Johnson Johnson, Alios BioPharma	Pre-clinical
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	Shanghai Meiye Biotechnology	Pre-clinical
Recombinant human interferon α	Interferon Alfa	Pending update	Tumor, Infectious diseases	Shanghai GeneCore BioTechnologies	Pre-clinical
Recombinant human serum albumin and interferon α-2b fusion protein	Recombinant human serum albumin and interferon α-2b-kangbao group	Pending update	Tumor, Infectious diseases	Wolwo Pharma	Pre-clinical
Recombinant human interferon α-2a-Tumor vascular specific binding peptidesNGR fusion protein	Pending update	Pending update	Tumor, Infectious diseases	JIUZHOU Group	Pre-clinical
Recombinant human interferon α-2b喷雾剂	Pending update	Pending update	Tumor, Infectious diseases	Amoytop	Pre-clinical
Recombinant human interferon α	Interferon Alfa	Pending update	Tumor, Infectious diseases	Ainos, Inc.	Pre-clinical
Q101 type Polyethylene glycol recombinant interferon α-2a	Q101 pegylation interferon α-2a, PEG-IFN-α-2a, Q-101	Pending update	Tumor, Infectious diseases	CSPC Pharma	Pending update
Pegylated Interferon α-2b	Pending update	Pending update	Tumor, Infectious diseases	Pharmstandard PJSC	Pending update
Polyethylene glycol recombinant interferon α-2a	Peginterferon Alfa-2a	Pending update	Tumor, Infectious diseases	CHITAI TIANQING	Pending update
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	Changchun Heberbiological Technology Co., Ltd	Pending update
Q101 type Polyethylene glycol recombinant interferon α-2a	Q101 pegylation interferon α-2a, PEG-IFN-α-2a, Q-101	Pending update	Tumor, Infectious diseases	CSPC Pharma	Pending update
Polyethylene glycol recombinant interferon α-2b	peginterferon alfa-2b	Pending update	Tumor, Infectious diseases	Amoytop	Pending update
Albumin interferon α	Albumin-Interferon Alfa, alb-IFN, Albinterferon	Pending update	Tumor, Infectious diseases	GSK, Novartis, Human Genome Sciences	Pending update
Recombinant human serum albumin and interferon α-2b fusion protein	Recombinant human serum albumin and interferon α-2b-kangbao group	Pending update	Tumor, Infectious diseases	Hangzhou Jiuyuan Gene Engineering Co., Ltd	Pending update
interferonα-2b	Pending update	Pending update	Tumor, Infectious diseases	AXXO Im- und Export GmbH	Pending update
Recombinant human interferon α-2a	Interferon alfa 2a	Pending update	Tumor, Infectious diseases	BioPartners GmbH	Pending update
interferonα-2b	AP-001	Pending update	Tumor, Infectious diseases	Helix BioPharma Corp.	Pending update
recombinant consensus interferon α	Recombinant consensus interferon α	Pending update	Tumor, Infectious diseases	SL Pharm	Pending update

All Categories

Interferon-α (INF-α)

Modality